產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CRK抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CRK抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CRK
Cat. Number:
Anti-CRK抗體KL-2763R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodes a member of an adapter protein family that binds to several tyrosine-phosphorylated proteins. Anti-CRK抗體The product of this gene has several SH2 and SH3 domains (src-homology domains) and is involved in several signaling pathways, recruiting cytoplasmic proteins in the vicinity of tyrosine kinase through SH2-phosphotyrosine interaction. The N-terminal SH2 domain of this protein functions as a positive regulator of transformation whereas the C-terminal SH3 domain functions as a negative regulator of transformation. Two alternative transcripts encoding different isoforms with distinct biological activity have been described. [provided by RefSeq, Jul 2008]
Also known as:
CRK; Crk p38; CRK isoform Anti-CRK抗體2; CrkII; CRK isoform II; CRKII; p38; Proto oncogene C crk; v crk avian sarcoma virus CT10 oncogene homolog; v crk sarcoma virus CT10 oncogene homolog; v crk sarcoma virus CT10 oncogene homolog (avian); Adapter molecule crk; Avian sarcoma virus CT10 (v crk) oncogene homolog.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Crk.
●
Predicted Molecular Weight: Anti-CRK抗體33kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CRK抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-CRK抗體must be determined by the end user.
kl146Mu01 血管內(nèi)皮生長(zhǎng)因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl146Ra01 血管內(nèi)皮生長(zhǎng)因子D(VEGFD)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
kl145Hu01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Mu01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl145Ra01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
kl144Hu01 血管內(nèi)皮生長(zhǎng)因子B(VEGFB)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Mu01 血管內(nèi)皮生長(zhǎng)因子B(VEGFB)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl144Ra01 血管內(nèi)皮生長(zhǎng)因子B(VEGFB)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl143Hu01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Mu01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Ra01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl949Hu01 轉(zhuǎn)化生長(zhǎng)因子β3(TGFβ3)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Mu01 轉(zhuǎn)化生長(zhǎng)因子β3(TGFβ3)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl949Ra01 轉(zhuǎn)化生長(zhǎng)因子β3(TGFβ3)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 3 (TGFb3)
kl218Hu01 轉(zhuǎn)化生長(zhǎng)因子β2(TGFβ2)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Mu01 轉(zhuǎn)化生長(zhǎng)因子β2(TGFβ2)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
kl218Ra01 轉(zhuǎn)化生長(zhǎng)因子β2(TGFβ2)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
